share_log

Citigroup Initiates Coverage On Voyager Therapeutics With Buy Rating, Announces Price Target of $12

Benzinga ·  Dec 2, 2024 19:41  · Ratings

Citigroup analyst Samantha Semenkow initiates coverage on Voyager Therapeutics (NASDAQ:VYGR) with a Buy rating and announces Price Target of $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment